Evidence map›Paper›PMID 18982327›Full record

ReviewSeminars in immunopathology2008

Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Ann P Chidgey, Natalie Seach, Jarrod Dudakov, Maree V Hammett, Richard L Boyd

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Review
  3. Thymic Engraftment byFrontiers in immunology · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Hematopoietic progenitor migration to the adult thymus.Annals of the New York Academy of Sciences · 2011
    Review
  11. Regeneration of dendritic cells in aged mice.Cellular & molecular immunology · 2010
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ann P ChidgeyMonash Immunology and Stem Cell Laboratories, Building 75, STRIP, Monash University, Wellington Rd, Clayton, 3800, Melbourne, Australia. ann.chidgey@med.monash.edu.au
Natalie Seach
Jarrod Dudakov
Maree V Hammett
Richard L Boyd

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poor immune recovery is characteristic of bone marrow transplantation and leads to high levels of morbidity and mortality. The primary underlying cause is a compromised thymic function, resulting from age-induced atrophy and further compounded by the damaging effects of cytoablative conditioning regimes on thymic epithelial cells (TEC). Several strategies have been proposed to enhance T cell reconstitution. Some, such as the use of single biological agents, are currently being tested in clinical trials. However, a more rational approach to immune restoration will be to leverage the evolving repertoire of new technologies. Specifically, the combined targeting of TEC, thymocytes and peripheral T cells, together with the bone marrow niches, promises a more strategic clinical therapeutic platform.

Indexed as

Hematopoietic Stem Cell TransplantationAnimalsClinical Trials as TopicEpithelial CellsHumansImmunity, CellularThymus GlandT-LymphocytesTransplantation Conditioning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.